Club drug use and addiction treatment for teens and adults

Common club drugs include MDMA (ecstasy or molly), ketamine, GHB, synthetic cannabinoids (like K2 or Spice), LSD, and psilocybin mushrooms. They're grouped together based on where and how they're typically used, not because they're chemically related — they range from stimulants and dissociatives to depressants and hallucinogens.

Yes. Synthetic cannabinoids are lab-made chemicals sprayed onto plant material and marketed as a marijuana alternative, but they're often far more potent and unpredictable than real cannabis. Because their chemical makeup varies from batch to batch, the effects and risks — including severe anxiety, psychosis, and even death — can be far more serious than those of natural marijuana.

Laboratory studies show that ketamine use can cause brain changes typical of a drug with addictive potential, and studies in humans show that regular ketamine use is associated with symptoms of addiction, including continued use despite problems, using more than intended, and tolerance. That said, more research is needed to determine exactly how addictive ketamine might be.

Research suggests MDMA is potentially addictive, although more research is still needed, and the FDA hasn't approved any medication specifically for treating MDMA use. Treatment typically focuses on behavioral therapy, addressing any co-occurring mental health conditions, and building healthier coping strategies, similar to treatment for other stimulant-related substance use.

Molly is another name for MDMA, and yes, it carries a real risk of psychological dependence, even though it's not considered addictive in the same way as substances like opioids or alcohol. People can develop a pattern of relying on molly for social comfort or emotional connection that becomes difficult to stop, even without classic physical withdrawal.

Not in the way substances like opioids or alcohol are. Research suggests LSD and psilocybin mushrooms don't typically lead to classic physical addiction, in part because unpleasant effects can make people less likely to want to use them again. That said, tolerance can develop quickly with repeated use, and psychological reliance or unsafe patterns of use are still possible.

Start with an honest, judgment-free conversation about what you're noticing and why you're concerned. Avoid ultimatums or shame, which tend to increase secrecy rather than openness. Encourage them to talk to a doctor or clinician, and let them know treatment options — like Charlie Health's virtual Intensive Outpatient Program (IOP) — exist for people ready to make a change.

An Intensive Outpatient Program (IOP) is a level of behavioral healthcare for people who need more support than traditional weekly therapy but don't require inpatient care. The goal is to help people manage mental health and substance use challenges while maintaining their daily routines and responsibilities. Our IOP is delivered to clients directly at home through a virtual platform. Each program runs 9–12 weeks and includes 10+ hours of care per week. That time is split across individual therapy and group sessions, with family therapy and psychiatry available when clinically indicated. Scheduling is flexible, with morning, afternoon, and evening options to fit around school, work, and other commitments.

Charlie Health is in-network with more than 600 insurance plans nationwide, including most major commercial plans, TRICARE, and Medicaid in select states. Most clients (60%) pay $0 out-of-pocket. To verify coverage, contact the Admissions Team directly or fill out the online intake form.